Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSamsung El.gdr Regulatory News (SMSN)

Share Price Information for Samsung El.gdr (SMSN)

Share Price is delayed by 15 minutes
Get Live Data
4,936.00    -24.00 (-0.48%)
Bid:
4,934.00
Ask:
4,940.00
Spread: 6.00 (0.122%)
Market Cap: $1.30t
SMSN Live PriceLast checked at - London Stock Exchange

Intraday Samsung El.gdr Share Chart

  • This share is an international stock.

Decision on Share Repurchase

18 Feb 2025 10:21

RNS Number : 5359X
Samsung Electronics Co. Ld
18 February 2025
 

Decision on Share Repurchase

 

 

1. Number of shares to be repurchased

Common

48,149,247

Other

6,636,988

2. Value of shares to be repurchased (Korean won)

Common

2,696,357,832,000

Other

303,642,201,000

3. Expected repurchase period

Start date

February 19, 2025

End date

May 16, 2025

4. Purpose of repurchase

To increase shareholder value and conduct employee stock-based compensation, etc.

5. Method of repurchase

Open market

6. Consignment investment brokers

Samsung Securities Co., Ltd.

Korea Investment & Securities Co, Ltd.

Shinhan Securities Co., Ltd.

KB Securities Co., Ltd.

IBK Securities Co.,Ltd

7. Holding status of treasury shares before repurchase

Repurchase within the allowable distribution profit (shares)

Common

50,144,628

Ratio (%)

0.8

Other

6,912,036

Ratio (%)

0.8

Other repurchase (shares)

Common

-

Ratio (%)

-

Other

-

Ratio (%)

-

8. Date of board resolution (confirmation date)

February 18, 2025

- Attendance of Independent Directors at the Board of Directors meeting

Present

6

Absent

0

- Attendance of auditors who are not

 Independent Directors

0

9. Daily order quantity limit

Common

5,246,563

Other

663,698

 

10. Other Information to Consider:

- Shares denoted as "other" are preferred shares.

- In Item 2 above, the value of shares to be repurchased is based on the closing price on the day before the board resolution (February 17, 2025). The actual amount may change depending on future stock price movements.

 ※ KRW 56,000 per common share and KRW 45,750 per preferred share

-In Item 4, the expected holding period and purpose of repurchase, in accordance with the Board resolution on February 18, 2025, shares worth KRW 500 billion are to be acquired for the purpose of the stock-based compensation including employee incentives, etc. The remaining KRW 2.5 trillion is to be acquired for the purpose of stabilizing the stock price and enhancing shareholder value.

Further details, including timing of cancellation and the actual number of shares to be cancelled, will be disclosed following the resolution of the Board of Directors in the future.

* To enhance motivation for business performance and enhance shareholder value, the Company has decided to implement a stock-based compensation program (RSA) for executive compensation. Under this program, stock-based compensation will constitute 50% or more of the 2024 Overall Performance Incentive (OPI). The Company plans to allocate a portion of the repurchased shares, amounting to approximately KRW 500 billion, to the RSA program.

* Under the RSA framework, the number of treasury shares for each executive was determined in January 2025 based on individual selections. The final allocation will be confirmed one year later, considering the stock price at that time. Once granted, executives will be restricted from selling the shares for a period of one to two years, in accordance with the program's terms.

- In Item 8 above, all Audit Committee members are Independent Directors.

- The calculation method for Item 9 above is the smaller of: [] and [the larger of and ].

  10% of the number of shares to be repurchased: 4,814,924 common; 663,698 preferred

  25% of average daily transaction volume for one month ending the day before the date of the board resolution: 5,246,563 common; 319,492 preferred

  1% of total number of issued shares: 59,697,825 common; 8,228,867 preferred

 

- No shares were repurchased prior to the decision to repurchase shares.

 

- Limit on the amount of repurchased shares (Korean won)

1. Limits to Dividendable profit under Commercial Act as of end-2024

226,239,016,662,399

2. Amount of repurchased shares since end-2024

1,237,265,394,240

3. Amount of dividends on profits and reserves for related profits decided at a general meeting of shareholders since end-2024

-

4. The interim dividend amount and related profit reserves decided by the board of directors since end-2024

-

Limit on the amount of repurchased shares

(1-2-3-4)

225,001,751,268,159

 

- Holding status of treasury shares before purchase (number of shares)

* on-market direct purchase

Stock type

Initial quantity

Changes

End quantity

purchase

disposal

cancellation

common

-

50,144,628

-

-

50,144,628

other

-

6,912,036

-

-

6,912,036

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCMZGMZGRLGKZM
Date   Source Headline
31st Oct 20249:02 amRNSDelisting and Listing of Stocks
31st Oct 20247:00 amRNSAnnouncement of Capex Plan for FY2024
31st Oct 20247:00 amRNS2024 3Q Earnings Release
31st Oct 20247:00 amRNSQuarterly Dividend for Third Quarter 2024
8th Oct 20247:00 amRNSNotice of 3Q 2024 Earning Release
8th Oct 20247:00 amRNS3Q 2024 Pre-Earnings Guidance
30th Aug 202410:52 amRNS2024 Half-year Business Report
31st Jul 20249:33 amRNSTransaction with Affiliate Company
31st Jul 20249:26 amRNSCharitable Contribution
31st Jul 20247:00 amRNS2024 2Q Earnings Release
31st Jul 20247:00 amRNSQuarterly Dividend for Second Quarter 2024
5th Jul 20247:55 amRNSNotice of 2Q 2024 Earnings Release Schedule
5th Jul 20247:45 amRNS2Q 2024 Pre-Earnings Guidance
28th Jun 20248:53 amRNSSustainability Report 2024
31st May 202410:23 amRNSCorporate Governance Report FY2023
31st May 20247:00 amRNS2024 1Q INTERIM BUSINESS REPORT
21st May 20249:34 amRNSNotice on Change of CEO
30th Apr 20248:10 amRNSTransactions with Affiliated Companies
30th Apr 20247:00 amRNS2024 1Q Earnings Release
30th Apr 20247:00 amRNSQuarterly Dividend for First Quarter 2024
30th Apr 20247:00 amRNS2023 Business Report
5th Apr 20247:11 amRNSNotice of 1Q 2024 Earnings Release Schedule
5th Apr 20247:00 amRNS1Q 2024 Pre-Earnings Guidance
20th Mar 20249:07 amRNSTransactions with Affiliated Companies
20th Mar 20249:05 amRNSResults of the 55th Annual General Meeting
21st Feb 20247:00 amRNSReference Material for 2024 AGM
20th Feb 20248:31 amRNSCharitable Contribution
19th Feb 20249:40 amRNS2023 Separate Financial Statements
19th Feb 20249:34 amRNS2023 Consolidated Financial Statements
31st Jan 20247:00 amRNSYear-End Dividend for FY2023
31st Jan 20247:00 amRNS2023 4Q Earning Release
31st Jan 20247:00 amRNSAnnouncement of Capex Result for FY2023
31st Jan 20247:00 amRNSTransactions with Affiliated Companies
31st Jan 20247:00 amRNSShareholder Return Program for FY2024-2026
9th Jan 20247:00 amRNSNotice of 4Q 2023 Earning Release
9th Jan 20247:00 amRNS4Q 2023 Pre-Earnings Guidance
1st Dec 202311:09 amRNSCharitable Contribution
30th Nov 20237:54 amRNSTransactions with Affiliated Companies
30th Nov 20237:34 amRNS2023 3Q Interim Business Report
6th Nov 20238:43 amRNSAnnouncement of Investor Relations Event
31st Oct 20237:21 amRNSTransactions with Affiliated Companies
31st Oct 20237:18 amRNSAnnouncement of Capex Plan for FY2023
31st Oct 20237:13 amRNSQuarterly Dividend for Third Quarter 2023
31st Oct 20237:10 amRNS2023 3Q Earning Release
11th Oct 20237:10 amRNSNotice of 3Q 2023 Earning Release
11th Oct 20237:04 amRNS3Q 2023 Pre-Earnings Guidance
21st Sep 20237:30 amRNS2022 Business Report
21st Sep 20237:29 amRNS2022 Separate Financial Statements
21st Sep 20237:29 amRNS2022 Consolidated Financial Statements
31st Aug 20238:15 amRNS2023 Half-year Business Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.